Skip to main content

Table 3 Descriptive outcomesb

From: Low barrier medication for opioid use disorder at a federally qualified health center: a retrospective cohort study

Outcome

historical control group

intervention group

N

90

113

3-month treatment retentionc

54 (60.0%)

72 (63.7%)

6-month treatment retentionc

42 (46.7%)

66 (58.4%)

6-month mortality

0 (0.0%)

a(0.8–8.8%)

6-month unintended opioid overdose

a(1.1–11.1%)

17 (15.0%)

  1. aCells containing a value of 1 to 10 or additional cells that allow the back calculation of those small cells were suppressed in accordance with Duke EHR cell suppression policy
  2. bThese are descriptive only with no formal statistical testing for group differences
  3. cRetention outcomes were calculated without excluding patients who had a care gap